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INTRODUCTION
Cystic disease of the spleen is an uncommon entity with an 
incidence of 0.07% in general population [1]. It is classified as 
either primary or secondary according to the presence or ab-
sence of an epithelial lining of the lumen [2].
The primary cysts are subdivided into parasitic and non-par-
asitic. Most cases of parasitic cysts result from infection by E. 
granulosus, a condition called splenic hydatid disease (SHD). 
SHD constitute up to 6% of cases of abdominal hydatid dis-
ease, since the spleen is the third most common affected organ 
by E. granulosus following the liver and the lungs [3,4]. Hu-
mans are the intermediate host and the disease is endemic in 
the Mediterranean area, New Zealand, Australia, and South 
America. According to a recent report, human hydatidosis in 
Greece declines from an annual incidence of 14.8 per 100,000 
inhabitants during 1967-1971 to 0.3 in 2008 [5].
Cases of isolated splenic involvement of hydatid disease (HD) 
are very infrequent even in endemic regions. Other sites such 
as the heart, pancreas, and muscles are very rarely involved. 
The development of HD in the spleen is uncommon due to 
the biological cycle of Echinococcus. A minor percentage (10-
20%) of the hexacanth embryos that escape the double liver-
pulmonary circulation (first and second Lemman’s filters) may 
spread to any organ or apparatus, including the splenic paren-
chyma, although other forms of propagation have been hy-
pothesized. Splenic echinococcosis may also arise by retrograde 
spread from the liver to the spleen via the hepatic portal and 
splenic veins in portal hypertension [4].
Splenic hydatic cysts can be complicated by secondary infec-
tions and fistulization to adjacent organs, even above the dia-
phragm. Moreover, a systemic anaphylactic reaction which is a 
life-threatening complication can occur after rupture of the hy-
datid cyst in the peritoneal cavity [6]. Radical surgery is the 
mainstay of treatment and chemotherapy is added using an-
thelmintic regimens to avoid recurrence. In this study, 2 cases 
of isolated SHD managed with open and laparoscopic sple-
nectomy are presented. 
CASES DESCRIPTION
Case 1
A 44-year-old male presented in our department with a 4 
week history of a non-specific abdominal pain. Upon his ad-
mission, physical examination was unremarkable and routine 
laboratory tests were within normal limits. Abdominal ultra-
sound showed enlarged spleen. Abdominal CT followed, which 
revealed a splenic calcified hydatid cyst, without involvement 
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of any other abdominal organs (Fig. 1A). Immunoblot assay 
for Echinococcus was positive. A laparoscopic splenectomy, us-
ing a 4 port technique with the patient in the right lateral posi-
tion was performed. The specimen was removed using a retriev-
al bag through a 7 cm left subcostal incision (Fig. 1B, C).
The patient had an uneventful postoperative course and he 
was discharged home on the 3rd postoperative day. Albenda-
zole therapy 10 mg/kg/day was started postoperatively and 
continued for 3 months. One year later the patient remains 
symptom free and no long-term complications were observed 
during the follow-up. 
Case 2
A 71-year-old female was admitted to our department com-
plaining of early satiety after meals and abdominal discom-
fort. Physical examination showed a palpable mass or splenic 
enlargement in the left hypochondrium. Routine laboratory 
studies were normal. An abdominal ultrasound revealed a cal-
cified splenic mass. Imaging investigation with abdominal CT 
scan showed a circumferentially calcified spleen (Fig. 2A). Se-
rologic tests for E. granulosus by immunoblot assay were posi-
tive. The patient underwent a formal open splenectomy with 
uneventful postoperative course, and she was discharged home 
on the 5th postoperative day (Fig. 2B, C). Histopathological 
results revealed a 9.5 cm cystic cavitary lesion with thick calci-
fied wall, being consistent with hydatid cyst. Chemotherapy 
with albendazole was used postoperatively, but it was early 
discontinued due to side effects of abdominal pain and head-
ache, which ended after therapy withdrawal. Patient remains 
symptom free 18 months after splenectomy. 
DISCUSSION
Greece and Eastern Europe are considered endemic regions 
for the E. granulosus complex [5]. At least 7 of 9 E. granulosus 
genotypes are infective to humans, 4 of which exist in Europe. 
Globally, most human cases of cystic echinococcosis are caused 
by the sheep strain G1 of E. granulosus which predominantly 
has a dog-sheep cycle [7]. Despite the decrease in rates of in-
fection, Greece stands among the top countries in Europe for 
hydatid disease prevalence and is considered as a public health 
issue yet. 
Spleen involvement of hydatic disease has no specific clini-
cal manifestations, and the diagnosis is usually established in-
cidentally during investigation of non-specific symptoms. SHD 
usually co-exists with liver hydatidosis, but rarely as in our cas-
es is the spleen solely affected. 
The commonest presentation is discomfort and pain in the 
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Fig. 1. Abdominal CT scan showing the calcified splenic cyst (A), intraoperative view of laparoscopic splenectomy (B), and splenec-
tomy specimen (C).
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Fig. 2. Abdominal CT scan showing the circumferentially calcified spleen (A), intraoperative view (B), and splenectomy specimen (C).  Vezakis et al.: Splenic hydatid cyst cases in Greece   149
left upper quadrant of the abdomen. Early satiety, renal arterial 
compression with systemic hypertension, spontaneous cutane-
ous fistulization, or segmental portal hypertension has also 
been reported as patient’s symptoms [7]. This rare presenta-
tion can be complicated by secondary infection and fistuliza-
tion to adjacent organs, even above the diaphragm. 
Confirmation of the diagnosis depends on imaging modali-
ties, mostly abdominal ultrasonography and computed tomo-
graphy (CT scan). Calcification of the cyst wall, presence of 
daughter cysts, cystic membranes, septa or hydatid sand are 
imaging findings consistent with SHD. In most cases serologic 
tests and imaging characteristics in combination indicate the 
correct diagnosis [8,9]. Hydatid cyst fluid lipoprotein antigen 
B (AgB) from E. granulosus is considered to be the most specific 
native or recombinant antigen for immunodiagnosis. The as-
say for human cysticercosis is based on a family of glycopro-
teins with molecular weight of 8 kDa with 98% sensitivity and 
100% specificity [10].
Treatment is mainly surgical and options depend on indi-
vidual patient and surgeon’s expertise as long as total splenec-
tomy, partial splenectomy, cyst enucleation and unroofing with 
omentoplasty have all been reported [11]. Percutaneous drain-
age of the splenic hydatid cyst with injection and consecutive 
reaspiration of a scolecidal agent (PAIR technique) has been 
proposed as an alternative, non-surgical therapy for patients at 
high anesthetic risk or who do not agree to surgery [4]. In ad-
dition, splenic salvage is being increasingly advocated to pre-
vent complications associated with splenectomy, mainly an 
overwhelming infection [2]. 
A point that has to be emphasized here is whether laparo-
scopic approach is equally safe to open surgery or not. Scepti-
cism about laparoscopic splenectomy for SHD existed due to 
concern of cyst rupture and spillage of the parasite with subse-
quent anaphylactic reaction or recurrent peritoneal hydatido-
sis. Those concerns have not been proved in reported laparo-
scopic series, and thus laparoscopic splenectomy for SHD is 
the mainstay of treatment of this benign disease [12]. Com-
plete splenectomy can be performed safely by laparoscopy (e.g., 
with hand-assistance), even for huge splenic cysts and offers 
all the benefits of minimally invasive procedures. However, in 
our second case, an open approach was preferred because of 
extensive probable adhesions of the calcified splenic cyst and 
close relation to the kidney indicated by the preoperative CT-
scan. 
The role of preoperative administration of anthelmintic ther-
apy in preventing recurrence of the disease is still controversial. 
Preoperative administration of anthelmintic drugs softens the 
cysts, reduces intracystic pressure facilitating their removal, and 
postoperative use reduces the rate of recurrence [13]. Accord-
ing to the WHO guidelines, preoperative administration should 
begin between 1 month and 4 days before surgery for alben-
dazole and 3 months before surgery for mebendazole. The use 
of anthelmintic agents may discontinue early, as in our second 
case, because of side effects. Rash, itching, and facial swellings 
are signs of allergic reactions which are the main reason of sus-
pending therapy. In addition, persistent dizziness or headache, 
weakness as well as abdominal cramps, are other common side 
effects which were presented in our patient [14]. Besides, in the 
treatment of splenic hydatidosis, postoperative anthelmintic 
therapy may or may not be used in case of splenectomy which 
is performed without any spillage of the cyst contents [15].
Isolated SHD can be presented with non-specific symptoms 
underlying clinical suspicion by the physician for prompt di-
agnosis which is usually late. Treatment is mainly surgical by 
laparoscopy, while organ-preserving procedures are achievable 
only in cases with early diagnosis.
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